Unichem Laboratories Ltd
UNICHEMLABUnichem Laboratories Ltd
UNICHEMLAB
Price Chart
Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| -22.22 | 1.22 | 0.95% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 44.31 | 5.09 | 0.71% |
Forecast & Ratings
Detailed ForecastPrice
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Unichem Laboratories Limited is a pharmaceutical company that manufactures active pharmaceutical ingredients (APIs or bulk actives).
Peers
Compare with peersSun Pharmaceutical Industries Ltd
Cipla Ltd
Dr Reddy's Laboratories Ltd
Mankind Pharma Ltd
Torrent Pharmaceuticals Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Hmm, looks like data is unavailable here. Please come back after some timeRevenue Forecast
Hmm, looks like data is unavailable here. Please come back after some timeEarnings Per Share Forecast
Hmm, looks like data is unavailable here. Please come back after some timeIncome
Balance Sheet
Cash Flow
Income Statement
| Financial Year | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1,222.18 | 1,351.39 | 882.81 | 3,553.47 | 1,280.29 | 1,195.84 | 1,285.33 | 1,317.34 | 1,381.54 | 1,579.04 | ||||||||||
Raw Materials | 455.97 | 476.53 | 262.42 | 387.73 | 477.13 | 422.92 | 467.52 | 457.36 | 533.73 | 1,566.46 | ||||||||||
| Power & Fuel Cost | 39.39 | 38.25 | 41.62 | 49.23 | 76.39 | 73.02 | 68.89 | 78.05 | 102.84 | |||||||||||
| Employee Cost | 223.20 | 255.92 | 169.04 | 200.64 | 238.52 | 273.28 | 306.97 | 330.49 | 356.41 | |||||||||||
| Selling & Administrative Expenses | 359.25 | 380.90 | 233.92 | 291.18 | 420.94 | 345.54 | 316.35 | 287.13 | 299.84 | |||||||||||
| Operating & Other expenses | 22.64 | 20.69 | 32.10 | 17.93 | 50.56 | 39.77 | -15.36 | 45.07 | 134.33 | |||||||||||
EBITDA | 121.73 | 179.10 | 143.71 | 2,606.76 | 16.75 | 41.31 | 140.96 | 119.24 | -45.61 | 12.58 | ||||||||||
| Depreciation/Amortization | 41.27 | 38.79 | 43.52 | 50.51 | 67.37 | 81.67 | 84.36 | 91.17 | 113.44 | 118.68 | ||||||||||
| PBIT | 80.46 | 140.31 | 100.19 | 2,556.25 | -50.62 | -40.36 | 56.60 | 28.07 | -159.05 | -106.10 | ||||||||||
| Interest & Other Items | 3.04 | 2.90 | 3.36 | 8.01 | 7.52 | 7.85 | 5.12 | 6.11 | 17.31 | 22.10 | ||||||||||
| PBT | 77.42 | 137.41 | 96.83 | 2,548.24 | -58.14 | -48.21 | 51.48 | 21.96 | -176.36 | -128.20 | ||||||||||
| Taxes & Other Items | 2.02 | 29.30 | -11.85 | 3.34 | -34.35 | 11.97 | 17.15 | -11.09 | 25.86 | 5.14 | ||||||||||
| Net Income | 75.40 | 108.11 | 108.68 | 2,544.90 | -23.79 | -60.18 | 34.33 | 33.05 | -202.22 | -133.34 | ||||||||||
| EPS | 8.31 | 11.91 | 11.96 | 315.72 | -3.38 | -8.55 | 4.88 | 4.69 | -28.72 | -18.94 | ||||||||||
| DPS | 2.00 | 2.00 | 3.00 | 5.00 | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 0.00 | ||||||||||
| Payout ratio | 0.24 | 0.17 | 0.25 | 0.02 | — | — | 0.82 | 0.85 | — | 0.00 |
Company Updates
Investor Presentation
Investor Presentation
Annual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFPeers & Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Unichem Laboratories Ltd | -14.65 | 1.22 | 0.95% |
| Sun Pharmaceutical Industries Ltd | 34.71 | 4.96 | 0.94% |
| Cipla Ltd | 34.93 | 4.13 | 0.70% |
| Dr Reddy's Laboratories Ltd | 21.38 | 4.14 | 0.69% |
Price Comparison
Compare UNICHEMLAB with any stock or ETFShareholdings
Promoter Holdings Trend
Increased Total Promoter Holding
In last 6 months, promoter holding in the company has increased by 19.27%
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Decreased Total Retail Holding
In last 3 months, retail holding in the company has decreased by 7.47%
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Dec 2022
Mar 2023
Jun 2023
Sep 2023
Shareholding History
Mutual Funds Holding Trend
Increased Mutual Fund Holding
In last 3 months, mutual fund holding of the company has increased by 2.46%
Top 5 Mutual Funds holding Unichem Laboratories Ltd
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
HDFC Small Cap Fund - Direct Plan - Growth Option Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 8.0434% | Percentage of the fund’s portfolio invested in the stock 1.03% | Change in the portfolio weight of the stock over the last 3 months 0.22% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 39/80 (+12) |
DSP Healthcare Fund - Direct - Growth Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 1.0526% | Percentage of the fund’s portfolio invested in the stock 1.82% | Change in the portfolio weight of the stock over the last 3 months 0.95% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 19/29 (+6) |
HDFC Pharma and Healthcare Fund Direct Growth Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 0.0570% | Percentage of the fund’s portfolio invested in the stock 0.33% | Change in the portfolio weight of the stock over the last 3 months 0.33% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 33/34 (-1) |
Compare 3-month MF holding change on Screener
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividend Cuts
UNICHEMLAB has increased or maintained dividend levels over the last 5 years
Dividend Yield
Current dividend yield is 0.95%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹9.51 every year
Dividends
Corp. Actions
Announcements
Legal Orders
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateAug 1, 2022
Dividend/Share
₹4.00
Ex DateEx Date
Aug 1, 2022
Cash Dividend
Ex DateEx DateJul 22, 2021
Dividend/Share
₹4.00
Ex DateEx Date
Jul 22, 2021
Cash Dividend
Ex DateEx DateAug 20, 2020
Dividend/Share
₹4.00
Ex DateEx Date
Aug 20, 2020
Cash Dividend
Ex DateEx DateJul 18, 2019
Dividend/Share
₹4.00
Ex DateEx Date
Jul 18, 2019
Cash Dividend
Ex DateEx DateJul 19, 2018
Dividend/Share
₹5.00
Ex DateEx Date
Jul 19, 2018
News & Opinions
Stocks to watch today: July 28, 2023
4 months ago•The Hindu Businessline
CCI approves Ipca Laboratories 59.38% stake buy deal in Unichem Laboratories
4 months ago•The Hindu Businessline
Better than most deals in recent years: Ipca on ‘expensive’ Unichem-buy
7 months ago•The Hindu Businessline
Ipca Labs shares tumble 9% on acquisition of stake in Unichem Laboratories
7 months ago•Economic Times
Ipca agrees to pick up 33% stake in Unichem
7 months ago•The Hindu Businessline
IPCA Labs To Acquire 33.38% Stake In Unichem Laboratories For Rs 1,034 Crore
7 months ago•Bloomberg Quint
IPCA Labs to buy 33.4% stake in Unichem Laboratories for Rs 1,034 crore
7 months ago•Business Standard
Lower than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of -17.22%, vs industry avg of 8.45%
Decreasing Market Share
Over the last 5 years, market share decreased from 1.75% to 0.43%